Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial

JO Schwab, M Gasparini, M Lunati… - Journal of …, 2009 - Wiley Online Library
Introduction: The purpose of this investigation is to evaluate whether a prolonged detection
interval for life threatening ventricular tachyarrhythmia (VT) is able to reduce therapies (Rx) …
被引用次数：28 相关文章

Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.

JO Schwab, M Gasparini, M Lunati… - Journal of …, 2009 - europepmc.org
Methods and results The ADVANCE III study is a prospective, randomized, parallel trial with
2 arms evaluating different intervals to detect (NID), ie, 18/24 (as currently used) versus …

Avoid Delivering Therapies for Nonsustained Fast Ventricular Tachyarrhythmia in Patients with Implantable Cardioverter/Defibrillator: The ADVANCE III Trial.

JO SCHWAB, M GASPARINI… - Journal of …, 2009 - search.ebscohost.com
Introduction: The purpose of this investigation is to evaluate whether a prolonged detection
interval for life threatening ventricular tachyarrhythmia (VT) is able to reduce therapies (Rx) …
[PDF] academia.edu

[PDF][PDF] Avoid Delivering Therapies for Nonsustained Fast Ventricular Tachyarrhythmia in Patients with Implantable Cardioverter/Defibrillator: The ADVANCE III Trial

T ADVANCE III - Journal of Cardiovascular Electrophysiology, 2008 - academia.edu
Methods and Results: The ADVANCE III study is a prospective, randomized, parallel trial
with 2 arms evaluating different intervals to detect (NID), ie, 18/24 (as currently used) versus …

Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial

JO Schwab, M Gasparini, M Lunati, A Proclemer… - 2009 - pubmed.ncbi.nlm.nih.gov
Introduction The purpose of this investigation is to evaluate whether a prolonged detection
interval for life threatening ventricular tachyarrhythmia (VT) is able to reduce therapies (Rx) …